Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bortezomib in PTEN-deficient Intrahepatic Cholangiocarcinoma
NCT03345303Phase 3Unknown
- Start
- Jan 2017
- Primary completion
- Dec 2020
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of bortezomib in intrahepatic cholangiocarcinoma (ICC). Status: unknown.
02
Drugs
bortezomib
03
Conditions
intrahepatic cholangiocarcinoma (ICC)
Beyond the preview
Go deeper on NCT03345303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03345303.